NIH Exploratory/Developmental Research Grant Program (Parent R21 Basic Experimental Studies with Humans Required) | PA 20 196

Opportunity Information: Apply for PA 20 196

The NIH Exploratory/Developmental Research Grant Program (Parent R21 Basic Experimental Studies with Humans Required), PA 20-196, is a discretionary NIH grant opportunity designed to fund early-stage, high-potential research ideas that are still in the exploratory or developmental phase. The R21 mechanism is meant for projects where investigators are testing new concepts, piloting emerging approaches, or generating key proof-of-concept data that could open up a new line of inquiry. NIH emphasizes that these projects can be higher risk than more mature proposals, but they should have a credible chance of producing important advances, such as a breakthrough insight or the creation of novel tools, agents, methods, models, or applications that could meaningfully shift a biomedical, behavioral, or clinical research field.

A defining feature of this specific Parent R21 announcement is that it is intended for basic science experimental studies involving humans that are classified as clinical trials under NIH rules, while still meeting NIH’s definition of basic research. In practical terms, the projects covered here are prospective studies where human participants are assigned to different conditions by the research team, meaning the investigators deliberately manipulate one or more independent variables (for example, altering a stimulus, task, exposure, intervention-like condition, or experimental context) and then measure biomedical or behavioral outcomes in humans. The key is the purpose: the study should be aimed at understanding fundamental mechanisms or phenomena rather than testing a product, protocol, or process with a specific practical or clinical application as the primary goal. NIH links this scope to the concept described in NOT-OD-18-212, which frames these as “prospective basic science studies involving human participants.”

This announcement draws a clear boundary around what belongs under this FOA versus other NIH clinical trial funding opportunities. If a project is being conducted with specific applications in mind, such as developing or validating a clinical process, optimizing a treatment protocol, evaluating an intervention for a defined applied endpoint, or otherwise moving directly toward a product or service, NIH indicates that applicants should use a different Funding Opportunity Announcement, typically one labeled “Clinical Trials Required” or “Clinical Trial Optional,” depending on the Institute or Center and the nature of the work. In other words, the presence of human participants and prospective assignment makes it a clinical trial for NIH purposes, but the scientific intent determines whether it belongs in this “basic experimental studies with humans” lane or in a more applied clinical trials lane.

Eligibility for this opportunity is broad and includes many common applicant types across academia, government, nonprofits, and industry. Eligible applicants include state, county, and city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments and other tribal organizations; public housing authorities/Indian housing authorities; nonprofits with and without 501(c)(3) status (other than institutions of higher education); for-profit organizations other than small businesses; small businesses; and individuals. This breadth reflects NIH’s general approach of allowing proposals from any capable organization or investigator that can meet the scientific, ethical, and administrative requirements for conducting research with human participants.

Programmatically, the proposed project must align with the mission and research interests of one or more participating NIH Institutes and Centers. That matters because NIH is decentralized: different Institutes and Centers fund different scientific areas, populations, diseases, and methodological priorities. Applicants are expected to ensure that their aims and topic area fit the priorities of an Institute or Center that participates in the Parent R21, since that fit influences where an application can be assigned and ultimately whether it is competitive for funding.

From the listing details, the sponsoring agency is the National Institutes of Health, the funding instrument is a grant, and the activity category is listed under education, environment, and health. The opportunity references multiple CFDA (assistance listing) numbers, including 93.113, 93.121, 93.173, 93.213, 93.242, 93.273, 93.279, 93.307, 93.361, 93.866, and 93.867, reflecting the many NIH components that may support R21 projects depending on scientific scope. The original closing date provided in the source data is 2025-01-07, and the opportunity was created on 2020-05-07. The award ceiling and expected number of awards are not specified in the provided text, which is common in parent announcements where funding levels can vary by Institute/Center and by annual appropriations.

Overall, this FOA is best understood as an entry point for innovative basic research studies that involve experimentally manipulating conditions in human participants to probe fundamental biological or behavioral mechanisms. It is intentionally structured to help investigators move bold ideas from concept to credible preliminary evidence, while still meeting NIH’s requirements for ethical oversight and reporting for clinical trials, even when the work is basic rather than applied.

• The National Institutes of Health in the education, environment, health sector is offering a public funding opportunity titled "NIH Exploratory/Developmental Research Grant Program (Parent R21 Basic Experimental Studies with Humans Required)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.113, 93.121, 93.173, 93.213, 93.242, 93.273, 93.279, 93.307, 93.361, 93.866, 93.867.
• This funding opportunity was created on 2020-05-07.
• Applicants must submit their applications by 2025-01-07. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, Individuals, For-profit organizations other than small businesses, Small businesses.

Apply for PA 20 196

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: